226 related articles for article (PubMed ID: 25268550)
1. The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates α-synuclein aggregation and membrane binding.
Ghosh D; Sahay S; Ranjan P; Salot S; Mohite GM; Singh PK; Dwivedi S; Carvalho E; Banerjee R; Kumar A; Maji SK
Biochemistry; 2014 Oct; 53(41):6419-21. PubMed ID: 25268550
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure.
Zhao K; Li Y; Liu Z; Long H; Zhao C; Luo F; Sun Y; Tao Y; Su XD; Li D; Li X; Liu C
Nat Commun; 2020 May; 11(1):2643. PubMed ID: 32457390
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease-associated mutations in α-synuclein alters its lipid-bound state.
Maltseva S; Kerr D; Turke M; Adams EJ; Lee KYC
Biophys J; 2024 Jun; 123(12):1610-1619. PubMed ID: 38702883
[TBL] [Abstract][Full Text] [Related]
4. Aggregation and phase separation of α-synuclein in Parkinson's disease.
Han W; Wei M; Xu F; Niu Z
Chem Commun (Camb); 2024 Jun; 60(52):6581-6590. PubMed ID: 38808534
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the alpha-synuclein folding landscape by a mutation related to Parkinson's disease.
Ferreon AC; Moran CR; Ferreon JC; Deniz AA
Angew Chem Int Ed Engl; 2010 May; 49(20):3469-72. PubMed ID: 20544898
[No Abstract] [Full Text] [Related]
6. Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation.
Galvagnion C; Buell AK; Meisl G; Michaels TC; Vendruscolo M; Knowles TP; Dobson CM
Nat Chem Biol; 2015 Mar; 11(3):229-34. PubMed ID: 25643172
[TBL] [Abstract][Full Text] [Related]
7. Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs.
Boyer DR; Li B; Sun C; Fan W; Sawaya MR; Jiang L; Eisenberg DS
Nat Struct Mol Biol; 2019 Nov; 26(11):1044-1052. PubMed ID: 31695184
[TBL] [Abstract][Full Text] [Related]
8. Membrane remodeling by α-synuclein and effects on amyloid formation.
Jiang Z; de Messieres M; Lee JC
J Am Chem Soc; 2013 Oct; 135(43):15970-3. PubMed ID: 24099487
[TBL] [Abstract][Full Text] [Related]
9. Biophysics of α-synuclein membrane interactions.
Pfefferkorn CM; Jiang Z; Lee JC
Biochim Biophys Acta; 2012 Feb; 1818(2):162-71. PubMed ID: 21819966
[TBL] [Abstract][Full Text] [Related]
10. Conformational dynamics of A30G α-synuclein that causes familial Parkinson disease.
Das D; Mattaparthi VSK
J Biomol Struct Dyn; 2023; 41(24):14702-14714. PubMed ID: 36961209
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the mechanisms of α-Synuclein-lipid interactions using site-directed mutagenesis.
Ali A; Holman AP; Rodriguez A; Osborne L; Kurouski D
Neurobiol Dis; 2024 Aug; 198():106553. PubMed ID: 38839022
[TBL] [Abstract][Full Text] [Related]
12. Bacterial Chaperones CsgE and CsgC Differentially Modulate Human α-Synuclein Amyloid Formation via Transient Contacts.
Chorell E; Andersson E; Evans ML; Jain N; Götheson A; Åden J; Chapman MR; Almqvist F; Wittung-Stafshede P
PLoS One; 2015; 10(10):e0140194. PubMed ID: 26465894
[TBL] [Abstract][Full Text] [Related]
13. Liquid-liquid phase separation of α-synuclein is highly sensitive to sequence complexity.
Mahapatra A; Newberry RW
Protein Sci; 2024 Apr; 33(4):e4951. PubMed ID: 38511533
[TBL] [Abstract][Full Text] [Related]
14. Copper(II) enhances membrane-bound α-synuclein helix formation.
Lucas HR; Lee JC
Metallomics; 2011 Mar; 3(3):280-3. PubMed ID: 21290070
[TBL] [Abstract][Full Text] [Related]
15. Chemoenzymatic Semisynthesis of Phosphorylated α-Synuclein Enables Identification of a Bidirectional Effect on Fibril Formation.
Pan B; Rhoades E; Petersson EJ
ACS Chem Biol; 2020 Mar; 15(3):640-645. PubMed ID: 32065743
[TBL] [Abstract][Full Text] [Related]
16. Insights into the Binding Interactions between Microplastics and Human α-Synuclein Protein by Multispectroscopic Investigations and Amyloidogenic Oligomer Formation.
Ghosal S; Bag S; Bhowmik S
J Phys Chem Lett; 2024 Jun; 15(25):6560-6567. PubMed ID: 38885454
[TBL] [Abstract][Full Text] [Related]
17. WT and A53T α-Synuclein Systems: Melting Diagram and Its New Interpretation.
Bokor M; Tantos Á; Tompa P; Han KH; Tompa K
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503167
[TBL] [Abstract][Full Text] [Related]
18. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases.
Chiti F; Calamai M; Taddei N; Stefani M; Ramponi G; Dobson CM
Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16419-26. PubMed ID: 12374855
[TBL] [Abstract][Full Text] [Related]
19. The first East Asian Parkinson's disease caused by A53E SNCA mutation with early progression to dementia.
Yoon YJ; Park CW; Kim JJ; Chung SJ; Kim YJ
J Mov Disord; 2024 Jun; ():. PubMed ID: 38867354
[No Abstract] [Full Text] [Related]
20. Structure based aggregation studies reveal the presence of helix-rich intermediate during α-Synuclein aggregation.
Ghosh D; Singh PK; Sahay S; Jha NN; Jacob RS; Sen S; Kumar A; Riek R; Maji SK
Sci Rep; 2015 Mar; 5():9228. PubMed ID: 25784353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
